Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

cobweb icon Archived: Gestational Diabetes: Screening

Original Release Date: May 2008

This version of this topic is currently archived and inactive. It should be used for historical purposes only.

Archived: Recommendation Summary

Summary of Recommendations

PopulationRecommendationGrade
(What's This?)
Pregnant Women, either before or after 24 weeks gestation

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus (GDM), either before or after 24 weeks gestation.

 
I

Go to the Figure for a summary of this recommendation and suggestions for clinical practice. Table 1 describes the USPSTF grades and Table 2 describes the USPSTF classification of levels of certainty about net benefit.

This recommendation statement was first published by the Annals of Internal Medicine.

Select for copyright and source information.

Archived: Related Information for Consumers

There is no related information for consumers.

Archived: Related Information for Health Professionals

There is no related information for health professionals.

Archived: Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: July 2015

Internet Citation: Final Update Summary: Gestational Diabetes: Screening. U.S. Preventive Services Task Force. July 2015.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/gestational-diabetes-screening1

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857